Daniel G Haller MD FACP, FASCO, FRCP

PubMed

• Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Diges...
  Jean-Baptiste Bachet, Aimery de Gramont, Morteza Raeisi, Manel Rakez, Richard M Goldberg
  Journal of Clinical Oncology. 2025-06-20
• 12 citations
  Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.
  Claire Gallois, Qian Shi, Jeffrey P Meyers, Timothy Iveson, Steven R Alberts
  Journal of Clinical Oncology. 2023-02-01
• Primary Chemoradiotherapy for Older Patients With Esophageal Cancer.
  Jennifer R. Eads, Daniel G. Haller
  JAMA Oncology. 2021-10-01

Journal Articles

• Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013  
  Price TJ, Segelov E, Burge M, Haller D, et al., Expert Rev Anticancer Ther., 8/1/2014
• Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013  
  Papamichael D, Audisio RA, Glimelius B, de Gramont A, Glynne-Jones R, Haller D,et al., Ann Oncol., 7/11/2014
• Epidemiology and natural history of central venous access device use and infusion pump function in the NO16966 trial  
  Chu E, Haller D, Cartwright T, et al., Br J Cancer, 2/18/2014
• Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration ...  
  Siq Q, Andre T Grothey A, Yothers, Hamilton SR, Bot B, Haller DG, Van Cutsem, Twelves C, Benedetti J, O’Connell MJ, Sargent DJ, JCO, 8/26/2013
• Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database  
  McCleary NJ, Meyerhardt JA, Green E, Yothers G, de Gramont A, Van Cutsem E, O’Connell MJ, Twelves CJ, Saltz, LB, Haller DG, Sargent DJ, JCO, 6/3/2013
• Current opinion on optimal treatment for colorectal cancer  
  Price TJ, Segelov E, Burge M, Haller DG, Ackland SP, Tebbutt NC, Karapetis CS, Pavlakis N, Sobrero AF, Cunningham D, Shapiro JD, Expert Rev Anticancer Ther., 5/1/2013
• Phase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296)  
  Chakravarthy AB, Catalano PJ, Mondschein JK, Rosenthal DI, Haller DG, Whittington R, Spitz FR, Wagner H, Sigurdson ER, Tschetter LK, Bayer GK, Mulcahy MF, Benson AB, Gastrointest Cancer Res, 11/1/2012
• Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection  
  Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson JA, Jessup JM, Stemmermann GN, Blanke CD, Macdonald JS, J Clin Oncol, 7/1/2012
• Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research: A Joint Journal and Pharmaceutical Industry Perspective  
  Mansi BA, Gonzalez J, Haller D, Mayo Clinic Proceedings, 5/1/2012
• Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma  
  Moghanaki D, Mick R, Furth EE, Sohal D, Salmon PM, Behbahani A, Morgans AK, Miller SM, Giantonio BJ, Whittington RW, Haller DG, JOP, 9/9/2011
• The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010  
  Van Cutsem E, Dicato M, Geva R, Arber N, Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M, Glynne-Jones R, Grothey A, Haller D, Ann Oncol, 6/1/2011
• Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or ir...  
  Sargent D, Shi Q, Yothers G, Van Cutsem E, Cassidy J, Saltz L, Wolmark N, Bot B, Grothey A, Buyse M, de Gramont A; Adjuvant Colon Cancer End-points (ACCENT) Group, Eur J Cancer, 5/1/2011
• Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced up...  
  Sun W, Metz JM, Gallagher M, O'Dwyer PJ, Giantonio B, Whittington R, Haller DG, Cancer Chemother Pharmacol, 3/1/2011
• Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol  
  Albert M, Kiefer MV, Sun W, Haller D, Fraker DL, Tuite CM, Stavropoulos SW, Mondschein JI, Soulen MC, Cancer, 1/15/2011
• Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting  
  Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, Gores G, Kerlan R, Merle P, O'Neil B, Poon R, Schwartz L, Tepper J, Yao F, Haller D, Mooney M, Venook A, J Clin Oncol, 9/1/2010
• Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancer  
  Manne SL, Coups EJ, Winkel G, Markowitz A, Meropol NJ, Lesko SM, Jacobsen PB, Haller D, Jandorf L, Peterson SK, Health Educ Res., 10/1/2009
• Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients wit...  
  Poplin E, Feng Y, Berlin J, Rothenberg ML, Hochster H, Mitchell E, Alberts S, O'Dwyer P, Haller D, Catalano P, Cella D, Benson AB 3rd, J Clin Oncol., 8/10/2009
• Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials  
  Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T, Zheng Y, Green E, Labianca R, O'Callaghan C, Seitz JF, Francini G, Haller D, Yothers G, Goldberg R, de..., J Clin Oncol, 2/1/2009
• The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007  
  Van Cutsem E, Dicato M, Haustermans K, Arber N, Bosset JF, Cunningham D, De Gramont A, Diaz-Rubio E, Ducreux M, Goldberg R, Glynne-Jones R, Haller D, Kang YK, Kerr D, ..., Ann Oncol, 6/1/2008
• Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set  
  Michael J. O'Connell, Megan E. Campbell, Richard M. Goldberg, Axel Grothey, Jean-Francois Seitz, Jacqueline K. Benedetti, Thierry Andre, Daniel G. Haller, Daniel J. Sa..., JCO, 5/10/2008
• Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines  
  Daniel G. Haller, Jim Cassidy, Stephen J. Clarke, David Cunningham, Eric Van Cutsem, Paulo M. Hoff, Mace L. Rothenberg, Leonard B. Saltz, Hans-Joachim Schmoll, Carmen ..., JCO, 5/1/2008
• Phase II Trial of Sunitinib in Patients With Metastatic Colorectal Cancer After Failure of Standard Therapy  
  Leonard B. Saltz, Lee S. Rosen, John L. Marshall, Robert J. Belt, Herbert I. Hurwitz, S. Gail Eckhardt, Emily K. Bergsland, Daniel G. Haller, A. Craig Lockhart, Caio M..., JCO, 10/20/2007
• End Points for Colon Cancer Adjuvant Trials: Observations and Recommendations Based on Individual Patient Data From 20,898 Patients Enrolled Onto 18 Randomized Trials ...  
  Daniel J. Sargent, Smitha Patiyil, Greg Yothers, Daniel G. Haller, Richard Gray, Jacqueline Benedetti, Marc Buyse, Roberto Labianca, Jean Francois Seitz, Christopher J..., JCO, 10/10/2007
• Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer  
  Dolinsky CM, Mahmoud NN, Mick R, Sun W, Whittington RW, Solin LJ, Haller DG, Giantonio BJ, O'Dwyer PJ, Rosato EF, Fry RD, Metz JM, J Surg Oncol, 9/1/2007
• Long-Term Results of RTOG Trial 8911 (USA Intergroup 113): A Random Assignment Trial Comparison of Chemotherapy Followed by Surgery Compared With Surgery Alone for Eso...  
  David P. Kelsen, Katryn A. Winter, Leonard L. Gunderson, Joanne Mortimer, Norman C. Estes, Daniel G. Haller, Jaffer A. Ajani, Walter Kocha, Bruce D. Minsky, Jack A. Ro..., JCO, 8/20/2007
• Join now to see all

Books/Book Chapters

• AJCC Cancer Staging Manual 
  Editors: Greene FL, Page DL, Fleming ID, Fritz A, Balch C, Haller DG, Morrow M.Springer-Verlag, New YorkEdition 6th,2002
• The Effective Management of Colorectal Cancer 
  Editors: Cunningham D, Haller D and Miles A.Aesculapius Medical Press, London2000
• The Consultation Guide 
  Chapter: Oncology. 
  Page 451 - 469Haller DGEditors: Ladenson PW.Lippincott Williams and Wilkins1999
• Colorectal Cancer 
  Chapter: Selected cooperative group trials in adjuvant treatment. 
  Page 378 - 388Haller DGEditors: Wanebo HJ.Mosby, St. Louis, MO1993
• Medical Oncology 
  Chapter: Endocrine Neoplasms. 
  Haller DGEditors: Calabresi P and Schein PS.McGraw-Hill, New York1993
• Medical Oncology 
  Chapter: Gastric Cancer. 
  Schein PS and Haller DGEditors: Calabresi P and Schein PS.McGraw-Hill, New York1993
• Gastrointestinal Oncology 
  Chapter: Carcinoid and Islet Cell Tumors. 
  Page 449 - 460Haller DGEditors: Ahlgren J, Macdonald JS.Lippincott, Philadelphia, PA1992
• Breast Cancer Treatment. A Comprehensive Guide to Management 
  Chapter: Metastatic Breast Cancer. 
  Haller DG, Fox KR, Schuchter LMEditors: Fowble B, Goodman RL, Glick JH, Rosato EF.Mosby Year-Book, St. Louis, MO1991
• Oncology Overview 
  Chapter: Management of Colorectal Neoplasms. 
  Haller, DGInternational Cancer Research Data Bank (ICRDB) Branch of the International Cancer Information Center (ICIC), US National Cancer Institute, Bethesda, MD1990
• Gastrointestinal Oncology 
  Chapter: Endocrine Producing Tumors of the Gastrointestinal Tract. 
  Haller DGEditors: Macdonald JS.Martinus Nijhoff, Boston1987
• The Biology and Treatment of Colorectal Cancer Metastases. 
  Chapter: Prognostic factors for liver metastases from colorectal cancer. 
  Page 253 - 263Haller DGEditors: Mastromarino A.Martinus Nijhoff, Boston1986
• Current Therapy in Hematology-Oncology 
  Chapter: Gastric Cancer 
  Haller DGEditors: M. Brain and P. Carbone.B.C. Decker, Toronto1985
• Hormone Producing Tumors of the Gastrointestinal Tract 
  Chapter: Chemotherapeutic Management of Endocrine Producing Tumors of the Gastrointestinal Tract. 
  Haller DGChurchill-Livingstone Inc., New York1985
• Medical Clinics of North America 
  Chapter: Lymphomas. 
  Haller DGEditors: W.B. Saunders Company.Philadelphia1984
• Neoplasms of the Large Intestine 
  Chapter: Chemotherapy of Advanced Colorectal Cancer. 
  Haller DGEditors: J.S. Spratt.W.B. Saunders Company, Philadelphia1984
• Adjuvant Therapy of Cancer IV 
  Chapter: Integration of adjuvant chemotherapy with definitive radiotherapy for primary breast cancer. 
  Glick JH, Danoff BF, Haller DGEditors: Jones SE and Salmons SE.Grune and Stratton Publishing Company, Orlando1984
• Concepts in Cancer Medicine 
  Chapter: Therapeutic Decision Making in Cancer Patients. 
  Page 289 - 302Haller DG, Glick JHEditors: S. Benham Kahn.Grune and Stratton Publishing Co., New York1983
• Breast Cancer: Alternatives to Mastectomy 
  Chapter: Adjuvant chemotherapy in patients undergoing definitive irradiation for primary breast cancer: The University of Pennsylvania experience. 
  Glick JH, Danoff BF, Haller DG, Weiler C, Goodman REditors: J Harris, S Hellman, W Silen.Lippincott, Philadelphia1983
• Adjuvant Therapy of Cancer III 
  Chapter: Adjuvant chemotherapy and radiotherapy following rectal surgery: An interim report from the GITSG. 
  Mittelman A, et al.Editors: Salmon SE and Jones SE.Grune and Stratton Publishing Company, New York1981
• Clinical Oncology (Computer Software Package) 
  Chapter: Management of Gastrointestinal Cancer. 
  Schein PS, Wolkoff AW, Haller DGGrune and Stratton Publishing Co., Orlando
• Join now to see all

Abstracts/Posters

• A phase II study of celecoxib (C) with irinotecan (I), 5-fluorouracil (F), and leucovorin (L) in patients (pts) with advanced or metastatic colorectal cancer (CRC).
  R. E. Sanborn, H. Lenz, D. G. Haller, A. B. Benson, T. Dragovich, C. Robles, M. McMahon, H. Li, M. Mori, N. Mattek, C. D. Blanke, Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings, 6/1/2006
• A phase II trial of combination of capecitabine, oxaliplatin with bevacizumab in treatment of advanced hepatocellular carcinoma (HCC): Preliminary safety analysis.
  M. Hewitt, W. Sun, D. G. Haller, K. Mykulowycz, C. M. Tuite, M. A. Rosen, M. C. Soulen, M. Caparro, B. J. Giantonio, K. M. Olthoff, Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings, 6/1/2006
• Extended safety and efficacy data on S-1 plus cisplatin in patients with advanced gastric carcinoma in a multi-center phase II study.
  H. Lenz Md, F. C. Lee, D. G. Haller, D. Singh, A. B. Benson, D. Strumberg, R. H. Yanagihara, J. C. Yao, A. T. Phan, J. A. Ajani, Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings, 6/1/2006
• Tolerability of fluoropyrimidines appears to differ by region.
  D. G. Haller, J. Cassidy, S. Clarke, D. Cunningham, E. Van Cutsem, P. Hoff, M. Rothenberg, L. Saltz, H. J. Schmoll, C. Twelves, Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings, 6/1/2006
• Phase I, combined modality studies of concurrent radiotherapy (XRT) with continuous infusion 5-FU, epirubicin, and cisplatin (ECF) or irinotecan (EIF) for locally adva...
  W. Sun, J. Metz, M. Gallagher, P. J. O'Dwyer, R. Whittington, B. Giantonio, D. G. Haller, Gastrointestinal Cancers Symposium, 1/1/2006
• Evidence for improved pathologic complete response (PCR) rate after preoperative chemoradiotherapy with 5-FU/oxaliplatin (5FU/OX) for rectal cancer.
  55. C. M. Dolinsky, N. N. Mahmoud, R. Mick, W. Sun, R. W. Whittington, L. J. Solin, D. G. Haller, P. J. O'Dwyer, R. D. Fry, J. M. Metz, Gastrointestinal Cancers Symposium, 1/1/2006
• Phase II trial of SU11248 in patients with metastatic colorectal cancer (MCRC) after failure of standard chemotherapy.
  H. Lenz, J. Marshall, L. Rosen, R. Belt, H. Hurwitz, S. Eckhardt, E. Bergsland, D. Haller, R. Chao, L. Saltz, Gastrointestinal Cancers Symposium, 1/1/2006
• Postoperative adjuvant chemoradiation for gastric or gastroesophageal adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-...
  C. Fuchs, J. E. Tepper, D. Niedwiecki, D. Hollis, D. G. Haller, T. Dragovich, S. R. Alberts, G. Bjarnason, R. J. Mayer, Gastrointestinal Cancers Symposium, 1/1/2006
• Early safety findings from a phase III trial of capecitabine plus oxaliplatin (XELOX) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with stage III colon can...
  H. J. Schmoll, J. Tabernero, M. Nowacki, J. Maroun, A. Figer, T. Price, R. Lim, E. van Cutsem, D. Haller, F. Braud, Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 7/1/2004
• A phase II trial of gefitinib in combination with 5-FU/LV/irinotecan in patients with colorectal cancer.
  M. Redlinger, A. Kramer, K. Flaherty, W. Sun, D. Haller, P. J. O'Dwyer, Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 7/1/2004
• A phase I trial of fixed-dose-rate (FDR) gemcitabine and irinotecan combination in patients with advanced pancreatic and biliary cancer.
  W. Sun, M. E. Theobald, D. Hershock, D. G. Haller, Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 7/1/2004
• Phase I study of GW572016 (lapatinib), a dual kinase inhibitor, in combination with irinotecan (IR), 5-fluorouracil (FU) and leucovorin (LV).
  R. Midgley, K. T. Flaherty, D. G. Haller, M. J. Versola, D. A. Smith, K. M. Koch, L. Pandite, D. J. Kerr, P. J. O'Dwyer, M. R. Middleton, Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 7/1/2004
• ONCOSURGE: A therapeutic decision model to optimize the management of colorectal liver metastases.
  D. G. Haller, S. Alberts, R. Adam, Y. Z. Patt, B. Nordlinger, H. Schmoll, J. Vauthey, J. N. Primrose, G. Poston, Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 7/1/2004
• Multi-Center Phase II Study of S-1 plus Cisplatin in Patients with Advanced Gastric Carcinoma (AGC).
  J. A. Ajani, A. Phan, J. C. Yao, F. Lee, D. A. Singh, D. Haller, A. B. Benson, H. Lenz, R. H. Yanagihara, D. Strumberg, Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 7/1/2004
• Adjuvant Chemotherapy in Patients with Hepatocellular Carcinoma After Orthotopic Liver Transplantation.
  W. Sun, S. S. Sonnad, E. E. Furth, K. Timmons, M. Caparro, B. J. Giantonio, D. Vaughn, D. G. Haller, A. Shaked, K. M. Olthoff, Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 7/1/2004
• Individualize the treatment of liver metastases from colorectal cancer using RAND appropriateness method: Oncosurge decision model. Results of a consensus detecting fr...
  G. Poston, D. Haller, J. Kahan, M. Cornelis, S. Mahyaoui, OncoSurge International Taskforce Group, Journal of Clinical , ASCO Annual Meeting Proceedings (Post-Meeting Edition), 1/1/2004
• Disease-free survival (DFS) vs. overall survival (OS) as a primary endpoint for adjuvant colon cancer studies: Individual patient data from 12,915 patients on 15 rando...
  D. J. Sargent, S. Wieand, J. Benedetti, R. Labianca, D. G. Haller, L. E. Shepherd, J. F. Seitz, G. Francini, A. De Gramont, R. M. Goldberg, Journal of Clinical , ASCO Annual Meeting Proceedings (Post-Meeting Edition), 1/1/2004
• Impact of TN stage and treatment on survival and relapse in adjuvant rectal cancer pooled analysis.
  L. L. Gunderson, D. Sargent, J. Tepper, N. Wolmark, M. O'Connell, M. Begovic, C. Allmer, L. Colangelo, S. Smalley, D. G. Haller, Proc ASCO, 1/1/2003
• Association of hospital procedure volume and outcomes in stage II and III colon cancer.
  J. A. Meyerhardt, P. J. Catalano, D. Schrag, J. Z. Ayanian, D. G. Haller, R. J. Mayer, J. S. MacDonald, A. B. Benson Iii, C. S. Fuchs, Proc ASCO, 1/1/2003
• ECOG 1297: A phase I study of preoperative radiaton therapy (RT) with concurrent protracted continuous infusion 5-FU and dose escalating oxaliplatin followed by surger...
  D. I. Rosenthal, P. Catalano, D. G. Haller, J. C. Landry, E. R. Sigurdson, F. R. Spitz, A. B. Benson, Proc ASCO, 1/1/2003
• Final results of a phase III trial of 5-FU/leucovorin versus oxaliplatin versus the combination in patients with metastatic colorectal cancer following irinotecan, 5-F...
  M. L. Rothenberg, A. M. Oza, B. Burger, J. Berlin, J. L. Marshall, R. K. Ramanathan, L. L. Hart, S. Gupta, C. A. Garay, D. G. Haller, Proc ASCO, 1/1/2003
• Phase II adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal (GE) junction and cardia (E8296): A trial of the Eastern Cooperative Onc...
  M. Y. Armanios, R. Xu, A. Forastiere, D. G. Haller, J. Kugler, A. B. Benson, Proc ASCO, 1/1/2003
• Postoperative adjuvant chemoradiation for gastric or gastroesophageal adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-...
  C. Fuchs, T. Fitzgerald, H. Mamon, D. G. Haller, A. Venook, P. Enzinger, R. Goldberg, L. Gunderson, R. Mayer, J. Tepper, Proc ASCO, 1/1/2003
• Using a pooled analysis to improve the understanding of adjuvant therapy (AT) benefit for colon cancer.
  S. Gill, C. L. Loprinzi, D. J. Sargent, D. G. Haller, J. Benedetti, G. Francini, L. E. Shepherd, J. F. Seitz, R. Labianca, R. M. Goldberg, Proc ASCO, 1/1/2003
• The oxaliplatin treatment access program: Compassionate use experience of oxaliplatin as a single agent or in combination with 5-fluorouracil in more than 7000 patient...
  R. A. Gams, R. K. Ramanathan, J. Clark, N. Kemeny, H.-J. Lenz, K. O. Gococo, D. G. Haller, E. Mitchell, E. Mitchell, C. Kardinal, Proc ASCO, 1/1/2003
• Join now to see all

Other

• Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer. Four year update. 
  Glick JH, Fowble B, Haller DG, Rosato EF, Mackie JA, Weiler C, Glover DJ, Fox KR, Hurwitz S, Goodman RL, NCI Monographs
  1/1/1988
• Adjuvant chemotherapy in colon and gastric cancer. 
  Macdonald JS, Haller DG, Kisner DL, Recent Results in Cancer Research, Vol. 80. Springer-Verlag
  1/1/1982